• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327

Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate (CAS No. 2090523-85-4): An Overview of a Promising Compound in Pharmaceutical Research

Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate (CAS No. 2090523-85-4) is a novel compound that has garnered significant attention in the field of pharmaceutical research due to its unique chemical structure and potential therapeutic applications. This compound belongs to the class of oxazoles, which are known for their diverse biological activities and structural versatility. In this article, we will delve into the chemical properties, synthesis methods, and recent research findings related to Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate.

The chemical structure of Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate consists of a five-membered oxazole ring with a methylamino substituent at the 2-position and a methyl ester group at the 5-position. This specific arrangement of functional groups imparts unique physical and chemical properties to the compound, making it an attractive candidate for various pharmaceutical applications.

One of the key aspects of Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate is its synthesis. Several synthetic routes have been reported in the literature, each with its own advantages and limitations. One common method involves the reaction of an appropriate nitrile with a methylamine derivative followed by cyclization to form the oxazole ring. Another approach involves the condensation of an aldehyde with a methylamine derivative and subsequent cyclization. These synthetic methods have been optimized to achieve high yields and purity, making large-scale production feasible.

Recent studies have focused on the biological activities of Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate. One notable area of research is its potential as an anti-inflammatory agent. In vitro studies have shown that this compound exhibits significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, it has been found to modulate immune responses by interacting with specific receptors on immune cells.

Beyond its anti-inflammatory properties, Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate has also shown promise in neuropharmacology. Preclinical studies have demonstrated its ability to cross the blood-brain barrier and exert neuroprotective effects. This makes it a potential candidate for treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The exact mechanisms underlying these effects are still under investigation, but preliminary data suggest that it may involve modulation of neurotransmitter systems and reduction of oxidative stress.

In addition to its therapeutic potential, Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate has also been studied for its use as a tool compound in drug discovery and development. Its structural features make it an excellent scaffold for designing new molecules with enhanced biological activities. Researchers have used this compound as a starting point to develop derivatives with improved pharmacokinetic properties and reduced side effects.

The safety profile of Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate is another important aspect that has been extensively studied. Toxicity assessments in animal models have shown that it is well-tolerated at therapeutic doses with no significant adverse effects observed. However, further clinical trials are necessary to fully evaluate its safety and efficacy in humans.

In conclusion, Methyl 2-(methylamino)-1,3-oxazole-5-carboxylate (CAS No. 2090523-85-4) is a promising compound with a wide range of potential applications in pharmaceutical research. Its unique chemical structure, diverse biological activities, and favorable safety profile make it an attractive candidate for further development. Ongoing research continues to uncover new insights into its mechanisms of action and therapeutic potential, paving the way for its potential use in treating various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)